Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2012

May 24, 2012

30071_dirs_2012-05-24_f824fd43-5843-41bc-b7c6-d52f8b4efce5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-05-22

Reporting Person: ROBERTS CHRISTOPHER G (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-05-22 ResMed Common Stock M 30000 $6.355 Acquired 30000 Direct
2012-05-22 ResMed Common Stock S 30000 $32.172 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-05-22 ResMed Stock Option $6.355 M 30000 Disposed 2012-07-11 ResMed Common Stock (30000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 302400 Indirect
ResMed Common Stock 136000 Indirect
ResMed Common Stock 23200 Indirect

Footnotes

F1: This trasnsaction was executed in multiple trades at prices ranging from $32.00 to $32.35. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.